hotspot -WSS

hotspot

author：fashion 2025-10-02 20:53:10 - browse：7

Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the company’s bid to secure Medicare coverage for its pricey blood-based cancer screening test that has been on the market for over a year but is not widely used.

A recently posted lobbying report indicates that, during the fourth quarter of last year, the biotech spent $1.07 million on “issues related to oncology and multi-cancer early detection,” including House and Senate bills that would allow Medicare to cover multi-cancer screening tests. That figure has been rising; during the fourth quarter of 2021, the company spent $470,000 on lobbying. That’s far more than cancer and genetic testing biotechs such as Guardant Health, Myriad Genetics, and Tempus, which spent anywhere from $90,000 to nearly $300,000 on lobbying last quarter.

The growing investment in lobbying elected officials comes at a time when Grail is looking to make its test, Galleri, available to a broader swath of the population. The test, launched in 2021, can detect early signs of more than 50 cancers among people who don’t have symptoms. That’s because cancer cells release bits of DNA into the bloodstream, and Galleri spots telltale modifications to this DNA.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Virtual repurposing can help discover new uses for existing drugs

WSS

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

The PBM ad wars are taking over Washington, D.C.

Study fuels hope CAR

CDC panel: People 65 and older should get a Covid spring booster shot

CDC advisory group OKs chikungunya vaccine

FDA approves Leqembi, a milestone in Alzheimer’s treatment

explore

hotspot

focus

At least 13 dead in Texas as scorching temps continue

Drinking water from half of US faucets contains PFAS: Study

State Dept. review finds Biden bears some blame for Afghanistan failures

Medicare isn't yet testing food as medicine

BioMarin wins approval for gene therapy to treat hemophilia A

Elisabeth Bik tackles the widespread issue of research misconduct

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Hollywood unions extend contract negotiations for actors

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

entertainment

Neutralizing antibodies against HIV shows promise in children

CDC advisory group OKs chikungunya vaccine

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Medicare Advantage isn’t working — for anyone

California man arrested in connection with serial murders of Mexican strip club workers

North Korean leader's powerful sister says warplanes repelled US spy plane

entertainment

Wikipedia

leisure time

hotspot